HMC CAPITAL LIMITED (HMC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HMC

HMC - HMC CAPITAL LIMITED

Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 1.5
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.25

03 Feb
2026

0.060

OPEN

$4.22

1.43%

HIGH

$4.27

1,079,912

LOW

$4.13

TARGET
$4.798 12.9% upside
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . BVS . CGF . CVW . DJW . ENN . GDG . GQG . HUB . IFL . IFT . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
HMC: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx 36.8 28.2 xxx
DPS (cps) xxx 12.0 12.0 xxx
EPS Growth xxx 94.7% - 23.3% xxx
DPS Growth xxx 0.0% 0.0% xxx
PE Ratio xxx N/A 14.8 xxx
Dividend Yield xxx N/A 2.9% xxx
Div Pay Ratio(%) xxx 32.6% 42.6% xxx

Dividend yield today if purchased 3 years ago: 2.33%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.87

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/08 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx36.8
DPS All xxxxxxxxxxxxxxx12.0
Sales/Revenue xxxxxxxxxxxxxxx249.2 M
Book Value Per Share xxxxxxxxxxxxxxx402.1
Net Operating Cash Flow xxxxxxxxxxxxxxx76.4 M
Net Profit Margin xxxxxxxxxxxxxxx59.11 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx10.22 %
Return on Invested Capital xxxxxxxxxxxxxxx10.19 %
Return on Assets xxxxxxxxxxxxxxx7.42 %
Return on Equity xxxxxxxxxxxxxxx10.22 %
Return on Total Capital xxxxxxxxxxxxxxx4.59 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx20.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx132 M
Long Term Debt xxxxxxxxxxxxxxx7 M
Total Debt xxxxxxxxxxxxxxx138 M
Goodwill - Gross xxxxxxxxxxxxxxx114 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx665 M
Price To Book Value xxxxxxxxxxxxxxx1.27

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx8.6 M
Capex % of Sales xxxxxxxxxxxxxxx3.45 %
Cost of Goods Sold xxxxxxxxxxxxxxx25 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx139 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.3

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

14/01/2026

1

Buy

$6.60

55.29%

UBS notes funds under management (FUM) mark-to-market revisions for wealth managers were mixed in December, with global equity markets buoyant but a weaker domestic market.

Returns in 4Q25 were also mixed, with domestic market declines partly offset by global equity and bond gains.

The broker cut HMC Capital's FY26 EPS forecast by a sharp -25.5% and FY27 by -1.7%. Target cut to $6.60 from $7.14, and Buy maintained.

This report was published January 5.

FORECAST
UBS forecasts a full year FY26 EPS of 26.90 cents.
UBS forecasts a full year FY27 EPS of 39.00 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

13/01/2026

3

Neutral

$4.00

-5.88%

Ahead of the February results season, sector analysts at Jarden have updated mark-to-market and valuations modeling, incorporating recent news flow and fresh insights.

Overall, sector earnings estimates have changed only slightly, and the same goes for valuations. The update has generated four changes in ratings for individual stocks in the sector.

The broker's forecast for HMC Capital's 1H26 FFO exceeds the consensus by 14.2%, but the analyst flags it is in line with the asset manager's FY26 guidance of 40c.

Neutral rating and $4 target price are unchanged.

HMC STOCK CHART